Abstract

AbstractMatrix metalloproteinases (MMPs) constitute a family of zinc‐dependent proteases involved in the extracellular matrix degradation. MMP‐2 and MMP–9 are overexpressed in several human cancer types, including melanoma, thus the development of new compounds to inhibit MMPs' activity is desirable. Molecular dynamic simulation and molecular properties calculations were performed on a set of novel β‐N‐biaryl ether sulfonamide‐based hydroxamates, reported as MMP‐2 and MMP‐9 inhibitors, for providing data to develop an exploratory analysis. Thermodynamic, electronic, and steric descriptors have significantly discriminated highly active from moderately and less active inhibitors of MMP‐2 whereas apparent partition coefficient at pH 1.5 was also significant for the MMP‐9 data set. Compound 47 was considered an outlier in all analysis, indicating the presence of a bulky substituent group in R3 is crucial to this set of inhibitors for the establishment of molecular interactions with the S1 subsite of both enzymes, but there is a limit. © 2012 Wiley Periodicals, Inc.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call